This post has been updated to clarify which of Myriad's claims were upheld by the Supreme Court.

So, if the US Supreme Court has now said that human genes are not patentable under US law, then why are the new gene testing companies that have jumped into the BRCA testing game in the wake of the ruling getting sued, the Washington Post WonkBlog's Timothy Lee asks.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.